Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yidan D. Zhao"'
Autor:
Yidan D Zhao, Lei Chu, Kathleen Lin, Elise Granton, Li Yin, Jenny Peng, Michael Hsin, Licun Wu, Amy Yu, Thomas Waddell, Shaf Keshavjee, John Granton, Marc de Perrot
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134958 (2015)
Pulmonary arterial hypertension (PAH) is a vascular disease characterized by persistent precapillary pulmonary hypertension (PH), leading to progressive right heart failure and premature death. The pathological mechanisms underlying this condition re
Externí odkaz:
https://doaj.org/article/6206184c122f48e9911f5a1b589d7096
Autor:
Xiaojia Huang, Kai Sun, Yidan D Zhao, Stephen M Vogel, Yuanling Song, Nadim Mahmud, You-Yang Zhao
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88814 (2014)
Adult stem cell-based therapy is a promising novel approach for treatment of acute lung injury. Here we investigated the therapeutic potential of freshly isolated human umbilical cord blood CD34(+) progenitor cells (fCB-CD34(+) cells) in a mouse mode
Externí odkaz:
https://doaj.org/article/514cdeb226e44827b13265758dc610e8
Autor:
Hu X, C. Knosalla, Yousef Al-Abed, de Perrot M, Wolfgang M. Kuebler, Neil M. Goldenberg, M.M. Kucherenko, Kevin J. Tracey, Yijie Hu, Yidan D. Zhao, Benjamin E. Steinberg, A. Volchuk
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Autor:
Licun Wu, Elise Granton, Yidan D. Zhao, Jenny Peng, Marc de Perrot, Kathleen Lin, Catherine Lu, Tiago N. Machuca, Shaf Keshavjee, Thomas K. Waddell
Publikováno v:
Pulmonary Circulation. 5:739-743
This study was undertaken to characterize the molecular and pathological mechanisms of pulmonary vascular remodeling in a patient who developed chronic lung allograft dysfunction and recurrent pulmonary hypertension (PH) 22 years after undergoing a r
Autor:
You Yang Zhao, Fan Yi, Khiem Tran, Chinnaswamy Tiruppathi, Zhijian Qian, Zhiyu Dai, Xiaojia Huang, Yidan D. Zhao
Publikováno v:
Stem Cells. 32:1855-1864
Adult stem cell treatment is a potential novel therapeutic approach for acute respiratory distress syndrome. Given the extremely low rate of cell engraftment, it is believed that these cells exert their beneficial effects via paracrine mechanisms. Ho
Autor:
Thomas K. Waddell, Licun Wu, Marc de Perrot, Shaf Keshavjee, Yidan D. Zhao, Lei Chu, Jenny Peng, Mingyao Liu, Li Yin, Ryan Michalek, John Granton, Hana Z. H. Yun
Publikováno v:
Metabolomics
Although multiple, complex molecular studies have been done for understanding the development and progression of pulmonary hypertension (PAH), little is known about the metabolic heterogeneity of PAH. Using a combination of high-throughput liquid-and
Publikováno v:
Stem Cells. 27:3112-3120
The goal of this study was to determine the role of integrin-mediated adhesion of bone-marrow-derived progenitor cells (BMPCs) as a requirement for the endothelial barrier protection in a lung injury model. C57BL mice were used as the source for BMPC
Autor:
Jenny Peng, Licun Wu, Kathleen Lin, Amy Yu, Thomas K. Waddell, Shaf Keshavjee, Lei Chu, John Granton, Yidan D. Zhao, Elise Granton, Michael Hsin, Li Yin, Marc de Perrot
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0134958 (2015)
PLoS ONE, Vol 10, Iss 8, p e0134958 (2015)
Pulmonary arterial hypertension (PAH) is a vascular disease characterized by persistent precapillary pulmonary hypertension (PH), leading to progressive right heart failure and premature death. The pathological mechanisms underlying this condition re
Autor:
Vladimir V. Kalinichenko, Muhammad K. Mirza, Yidan D. Zhao, I-Ching Wang, Robert H. Costa, You Yang Zhao, Asrar B. Malik, Xiaopei Gao, Randall S. Frey
Publikováno v:
Journal of Clinical Investigation. 116:2333-2343
Recovery of endothelial integrity after vascular injury is vital for endothelial barrier function and vascular homeostasis. However, little is known about the molecular mechanisms of endothelial barrier repair following injury. To investigate the fun
Autor:
Judy Trogadis, Yidan D. Zhao, R. N. N. Han, Duncan J. Stewart, Malcolm J. Robb, Yupu P. Deng, David W. Courtman, Doug S. Ng
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 35:182-189
Pulmonary arterial hypertension (PAH) is characterized by widespread loss of pulmonary microvasculature. Therefore we hypothesized that angiogenic gene therapy would reverse established PAH, in part restoring the lung microcirculation. Three weeks af